These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 10994678)
1. Defining an appropriate management strategy for social anxiety disorder. Davidson JR Int Clin Psychopharmacol; 2000 Jul; 15 Suppl 1():S13-7. PubMed ID: 10994678 [TBL] [Abstract][Full Text] [Related]
2. [The characteristics of treating social phobia]. Iakovlev VA Voen Med Zh; 1998 Jan; 319(1):54-6. PubMed ID: 9505549 [No Abstract] [Full Text] [Related]
3. Pharmacotherapy of social anxiety disorder. Davidson JR J Clin Psychiatry; 1998; 59 Suppl 17():47-53. PubMed ID: 9811430 [TBL] [Abstract][Full Text] [Related]
4. Social phobia: biological aspects and pharmacotherapy. Potts NL; Davidson JR Prog Neuropsychopharmacol Biol Psychiatry; 1992 Sep; 16(5):635-46. PubMed ID: 1353896 [TBL] [Abstract][Full Text] [Related]
5. Facing the challenge of social anxiety disorder. Westenberg HG Eur Neuropsychopharmacol; 1999 Jul; 9 Suppl 3():S93-9. PubMed ID: 10523064 [TBL] [Abstract][Full Text] [Related]
6. Monoamine oxidase inhibitors and alprazolam in the treatment of panic disorder and agoraphobia. Sheehan DV Psychiatr Clin North Am; 1985 Mar; 8(1):49-62. PubMed ID: 2859580 [TBL] [Abstract][Full Text] [Related]
7. Pharmacotherapy of social anxiety disorder. Ganasen KA; Stein DJ Curr Top Behav Neurosci; 2010; 2():487-503. PubMed ID: 21309123 [TBL] [Abstract][Full Text] [Related]
12. Some current treatment options for symptoms of anxiety. Shader RI; Greenblatt DJ J Clin Psychiatry; 1983 Nov; 44(11 Pt 2):21-30. PubMed ID: 6139367 [TBL] [Abstract][Full Text] [Related]
13. The evidence-based pharmacotherapy of social anxiety disorder. Blanco C; Bragdon LB; Schneier FR; Liebowitz MR Int J Neuropsychopharmacol; 2013 Feb; 16(1):235-49. PubMed ID: 22436306 [TBL] [Abstract][Full Text] [Related]
14. The role of drug therapy in social phobia. Lydiard RB J Affect Disord; 1998 Sep; 50 Suppl 1():S35-9. PubMed ID: 9851577 [TBL] [Abstract][Full Text] [Related]
16. Towards rational therapy with monoamine oxidase inhibitors. Tyrer P Br J Psychiatry; 1976 Apr; 128():354-60. PubMed ID: 4189 [TBL] [Abstract][Full Text] [Related]
17. Social anxiety disorder: a common, underrecognized mental disorder. Bruce TJ; Saeed SA Am Fam Physician; 1999 Nov; 60(8):2311-20, 2322. PubMed ID: 10593322 [TBL] [Abstract][Full Text] [Related]
18. WCA recommendations for the long-term treatment of social phobia. Van Ameringen M; Allgulander C; Bandelow B; Greist JH; Hollander E; Montgomery SA; Nutt DJ; Okasha A; Pollack MH; Stein DJ; Swinson RP; CNS Spectr; 2003 Aug; 8(8 Suppl 1):40-52. PubMed ID: 14767397 [TBL] [Abstract][Full Text] [Related]
19. Pharmacotherapy of social anxiety disorder at the turn of the millennium. Van Ameringen M; Mancini C Psychiatr Clin North Am; 2001 Dec; 24(4):783-803. PubMed ID: 11723633 [TBL] [Abstract][Full Text] [Related]
20. Recent developments in the psychopharmacology of social phobia. Den Boer JA; van Vliet IM; Westenberg HG Eur Arch Psychiatry Clin Neurosci; 1995; 244(6):309-16. PubMed ID: 7772614 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]